Exchange: NASDAQ·Updated 07:30 PM EST

STAA News

News
all
press releases
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of +78.95% and +2.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of +78.95% and +2.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Staar Surgical (NASDAQ:STAA) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzingaread more...
Benzinga
STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today reported results for the third quarter ended October 2, 2026. The Company will host an earnings call and webcast...
Business Wire
Merit Medical (MMSI) delivered earnings and revenue surprises of +7.69% and +1.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced the appointment of Pascal Aeschlimann as Vice President of Asia Pacific, effective November 2, 2026. Mr...
Business Wire
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that Warren Foust, President and Chief Executive Officer, and Deborah Andrews, Executive Vice President and Chief Financial...
Business Wire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA) SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation...
PR Newswire
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that it will release financial results and a letter to shareholders for the third quarter ended October 2, 2026, on Wednesday...
Business Wire
STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced the appointment of Andrew Pilon, O.D. as Vice President of Business Development. Dr. Pilon will report...
Business Wire

Advertisement|Remove ads.